Clinical Trial: A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers (China)

China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131972

Registration Time: 2026/09/08

Type: Interventional study

Primary Sponsor: Hopeshine-Minsheng Hos pital of Xinzheng

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333386

Published by HT Digital Content Services with permission from Health Daily Digest....